Skip to main content

Table 3 Causative agents of HAIs, stratified across HAI types

From: Incremental costs of hospital-acquired infections in COVID-19 patients in an adult intensive care unit of a tertiary hospital from a low-resource setting

Isolates

Total

PN

BSI

GI

UTI

SSI

(n, %)

Acinetobacter spp.

52 (43.0)

36 (65.5)

15 (28.3)

 

1 (50.0)

 

Coagulase-negative Staphylococcus

17 (14.0)

2 (3.6)

15 (28.3)

   

Enterococcus spp.

10 (8.3)

1 (1.8)

6 (11.3)

 

1 (50.0)

2 (40.0)

Pseudomonas aeruginosa

10 (8.3)

7 (12.7)

2 (3.8)

  

1 (20.0)

Clostridium difficile

6 (5.0)

  

6 (100.0)

  

Klebsiella spp.

5 (4.1)

2 (3.6)

3 (5.7)

   

Proteus mirabilis

5 (4.1)

2 (3.6)

1 (1.9)

  

2 (40.0)

Other Staphylococcal species

3 (2.5)

 

3 (5.7)

   

Staphylococcus aureus

3 (2.5)

2 (3.6)

1 (1.9)

   

Diphtheroids

3 (2.5)

1 (1.8)

2 (3.8)

   

Providencia spp.

3 (2.5)

2 (3.6)

1 (1.9)

   

Stenotrophomonas maltophilla

2 (1.7)

 

2 (3.8)

   

Achromobacter xylooxidans

2 (1.7)

 

2 (3.8)

   

Total

121

55

53

6

2

5

  1. PN - Pneumonia; BSI - bloodstream infection; GI - gastrointestinal infection; UTI - urinary tract infection; SSI - skin and soft tissue infection